pharmaphorum

MARCH 19, 2021

The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The webinar will also cover: How HCP engagement changed for pharma in 2020. How engagement with HCPs will evolve in the future.

Compounding 141

Compounding Pharmaceutical Companies Pharmaceutical Companies Communication 141

STAT

JULY 27, 2023

When Crystal Shih Byers left her job at Novartis in 2020, she was excited to make the leap into a smaller startup. But pharmaceutical companies are large and complex, and she craved more immediate impact. Byers had spent almost nine years at Novartis, most recently helping lead a group that worked on gene therapy.

Pharmaceutical Companies 90

Pharmaceutical Companies Pharmaceutical Companies 90

pharmaphorum

DECEMBER 9, 2020

The COVID-19 pandemic has been mainstream headline news throughout 2020 and continues to have a profound impact on all our lives. — Professor Karol Sikora (@ProfKarolSikora) April 22, 2020. — Tatiana Prowell, MD (@tmprowell) May 11, 2020. — Aditya Bardia, MD (@ABhealer108) March 14, 2020.

Hospitals 124

Hospitals Clinic Management Pharmaceutical Companies Pharmaceutical Companies 124

pharmaphorum

JANUARY 5, 2021

Healthcare systems ended 2020 in a very different place to where they were in 2019, with hospital capacity (and hospital finances) challenges. For pharmaceutical companies there are a number of implications. The EMA’s new medicines evaluation process seems similarly unaffected in 2020.

Hospitals 105

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

APRIL 16, 2021

IQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity for companies to focus on and address in 2021. It is undeniable that 2020 was a particularly challenging year to launch non-COVID innovative prescription medicines.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Documentation Vaccines 95

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

pharmaphorum

OCTOBER 20, 2020

The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 122

European Pharmaceutical Review

JANUARY 12, 2024

A key producer of innovative medicines: increasing manufacturing capacity Boehringer Ingelheim’s facility in Koropi is the only industrial facility of a multinational pharmaceutical company in Greece producing innovative medicines, the company acknowledged.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

JANUARY 16, 2023

AI has been voted as the most disruptive emerging technology every year since 2020, according to the survey tracker. The report also suggested that Big Data was thought to be the most important partner to AI, in terms of introducing technology-related changes in the pharmaceutical sector (Figure 2).

Pharmaceutical Companies 121

Pharmaceutical Companies Pharmaceutical Companies Vaccines 121

pharmaphorum

OCTOBER 18, 2021

What remains very clear is that collaboration between sponsor companies, health authorities and other stakeholders will be required to move this forward. Regulators and pharmaceutical companies are investigating cloud-based platforms to enable the real-time sharing of data. A Timeline of COVID-19 Developments in 2020.

Vaccines 143

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 143

pharmaphorum

MAY 13, 2021

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Veeva is the global leader in cloud software for the life sciences industry.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

MAY 20, 2022

Several of the top pharmaceutical companies have joined a new coalition that aims to improve access to cancer medicines in low- and lower-middle-income countries (LLMICs). million in 2020 to 4 million by 2040, according to ATOM’s members.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Hospitals 111

The Guardian - Pharmaceutical Industry

OCTOBER 16, 2022

Disregard for manufacturing standards could ruin the country’s reputation as the ‘developing world’s pharmacy’ and risk wider problems globally India’s reputation as the “pharmacy of the developing world”, built assiduously by the country’s pharmaceutical companies since the time of the Aids epidemic, is in serious jeopardy.

Pharmaceutical Companies 74

Pharmaceutical Companies Pharmaceutical Companies 74

pharmaphorum

NOVEMBER 10, 2020

The country will provide further momentum during its presidency of the Council of the European Union (EU), which runs from July until December 2020 and will see it work closely with the succeeding presidencies of Portugal and Slovenia. The post Germany’s digital health changes will boost digital therapeutics in Europe appeared first on.

Pharmaceutical Companies 72

Pharmaceutical Companies Pharmaceutical Companies 72

European Pharmaceutical Review

OCTOBER 24, 2022

In 2020-21, the loss of industry research during the pandemic is estimated to have generated an NHS deficit of up to £447 million. The report found that consistently slow and variable study setup and recruitment timelines in the NHS are forcing some pharmaceutical companies to place their trials in other countries.

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies Patient Care Vaccines 91

Pharma Marketing Network

JANUARY 6, 2021

Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Throughout 2020, the use of telehealth and remote monitoring has also drastically increased and may continue to be popular tools used between patients and HCPs in the year 2021.

Communication 98

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

AUGUST 1, 2022

Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. The pandemic forced governments to acknowledge that this status quo had to change.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies Chemotherapy 93

European Pharmaceutical Review

OCTOBER 7, 2022

Large CMOs held the biggest share of revenue in 2021, as even from the initial stages of drug production, pharmaceutical firms decided to outsource the work to these organisations.

Dosage 98

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

MAY 10, 2023

This marks a significant development in a tumultuous dispute between the pharmaceutical company and the US government. In November 2019, the government sued Gilead over the company’s alleged patent infringement of the two PrEP drugs Descovy and Truvada.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies FDA 105

pharmaphorum

SEPTEMBER 21, 2021

RwHealth , the leading provider of Artificial Intelligence to the healthcare industry, has today reported 160 per cent year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and major pharmaceutical companies.

Hospitals 118

Hospitals Pharmaceutical Companies Pharmaceutical Companies Patient Care 118

pharmaphorum

NOVEMBER 3, 2021

The report refers to data collected across 350+ global pharma companies between November 2020 through January 2021, and notes a 70% compound average growth rate in the volume of content managed in Veeva Vault PromoMats since 2018. Veeva is the global leader in cloud software for the life sciences industry.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies Communication 98

pharmaphorum

JANUARY 22, 2021

Source: CRA market research (conducted June 2020). More than 100,000 MS patients were included in the data set, defined as patients with two or more MS-related medical claims or one or more MS-related medical claims plus a related pharmacy claim identified between January 2019 and June 2020. Changes in Prescribing by Specialty.

Specialty Pharmacies 105

Specialty Pharmacies Pharmaceutical Companies Pharmaceutical Companies Vaccines 105

Pharma Marketing Network

AUGUST 26, 2020

In office/in person sales promotion, the staple of pharmaceutical company activities, is simply not possible today with interactions reduced to the sporadic video or to telephone engagement. This will result in permanent shifts in how HCPs and patients interact with pharmaceutical companies.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Compounding 98

pharmaphorum

MAY 13, 2022

Its chief digital and technology officer Lidia Fonseca offered a fascinating insight into how one biggest pharmaceutical companies – and one of those most closely associated with the pandemic (alongside the likes of BioNTech, Moderna and AstraZeneca) – has been transforming itself. Digital fluency and change.

Pharmaceutical Companies 131

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 131

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 113% rise in company filings mentions of cybersecurity in Q1 2023 compared with the previous quarter, with the highest share accounted for by Alnylam Pharmaceuticals with 114% year-on-year increase, according to GlobalData’s analysis of over 667 pharmaceutical company filings.

Pharmaceutical Companies 81

Pharmaceutical Companies Pharmaceutical Companies 81

The Checkup by Singlecare

MARCH 8, 2024

The pharmaceutical company that makes Amjevita is called Amgen, Inc. The pharmaceutical company that makes Cyltezo is called Boehringer Ingelheim Pharmaceuticals, Inc. The pharmaceutical company that makes Hyrimoz is called Cordavis Limited. Cyltezo is citrate-free.

Dosage 97

Dosage Pharmaceutical Companies Pharmaceutical Companies FDA 97

European Pharmaceutical Review

AUGUST 1, 2022

The DDiCT initiative aligns with the pharmaceutical company’s broader diversity and inclusion goals for 2020-2025, which aim to address health disparities, clinical trial diversity, supplier diversity, employee giving and workforce representation.

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies FDA 122

pharmaphorum

SEPTEMBER 3, 2020

In this article, I reflect on how the three COVID crises are reshaping the way in which innovative pharmaceutical companies engage with all their customers, and in particular how they consider their commercial models and innovative launch strategies. Challenges ahead.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies 97

European Pharmaceutical Review

JULY 5, 2022

In the same statement, Pfizer also announced it has signed a pledge by the US Department of Health and Human Services (HHS) that calls on US healthcare system stakeholders such as hospitals, health systems, payers, suppliers and pharmaceutical companies to reduce GHG emissions and build a more climate resilient healthcare infrastructure.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Hospitals 111

pharmaphorum

NOVEMBER 24, 2020

As lockdowns started in the West during March 2020, there was, inevitably, much punditry on exit scenarios – for economies, populations, and healthcare systems. Pharmaceutical companies cannot address this challenge alone. Considerable time was devoted to the discussion of V- , U- and L-shaped recoveries.

Pharmaceutical Companies 90

Pharmaceutical Companies Pharmaceutical Companies Vaccines Chemotherapy 90

pharmaphorum

DECEMBER 21, 2021

In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Despite the success tied to the vaccine rollout, analysing data is still a daily challenge for many life sciences and pharmaceutical companies.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 115

pharmaphorum

AUGUST 23, 2020

German pharmaceutical company Merck has appointed Thomas Möller as its new head of group communications. Birnstiel (pictured left) had headed Merck’s group communications since 2017 having joined the company after working for Siemens, Osram, E.ON and Uniper.

Communication 59

Communication Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 113% rise in company filings mentions of cybersecurity in Q1 2023 compared with the previous quarter, with the highest share accounted for by Alnylam Pharmaceuticals with 114% year-on-year increase, according to GlobalData’s analysis of over 667 pharmaceutical company filings.

Pharmaceutical Companies 75

Pharmaceutical Companies Pharmaceutical Companies 75

Pharmaceutical Technology

AUGUST 26, 2022

The Bill and Melinda Gates Medical Research Institute (Gates MRI) has previously teamed up with major pharmaceutical companies to advance TB research, but the development of these new drug regimens is a new step in their collaborative efforts. GlobalData is the parent company of Pharmaceutical Technology.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Documentation 98

pharmaphorum

MARCH 2, 2021

billion investment in equity finance in the sector in 2020. According to a report last month from the BioIndustry Association, covering life sciences and biotech, there was a record $2.8

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

APRIL 8, 2024

A study investigating the trend for existing pharmaceutical companies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. Yoshiura et al. Yoshiura et al. Yoshiura et al.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding 52

pharmaphorum

JANUARY 4, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson have submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA), seeking approval of talquetamab for the treatment of patients with relapsed or refractory multiple myeloma (RRMM).

FDA 98

FDA Pharmaceutical Companies Pharmaceutical Companies 98